ASX Share rice
Tue 04 Aug 2020 - 09:17:am (Sydney)

ATX Share Price

AMPLIA THERAPEUTICS LIMITEDATXPharmaceuticals, Biotechnology & Life Sciences

ATX Company Information


Amplia Therapeutics Limited





GIC Industry:


GIC Sub Industry:



55 Collins Street Melbourne VIC Australia 3000


61 2 8003 3650

CEO, MD & Director:

Dr. John Lambert B.Sc., BSc (Hons), MRACI, C.Chem., Ph.D.

Chief Financial Officer:

Mr. Jeff Carter

Company Sec.:

Mr. Andrew John Cooke L.L.B., LLB, FAICS, MAICD, FGIA, FCIS

Chief Scientific Advisor:

Mark Devlin B.Sc., Ph.D.

Founding Scientist:

Dr. Frank Gelder

Company Overview:

Amplia Therapeutics Limited, a pharmaceutical company, focuses on advancing a pipeline of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its clinical development pipeline comprises two lead molecules, AMP945 and AMP886 that inhibits (FAK). The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

ATX Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


ATX CashFlow Statement

CashFlow Date:


Change To Liabilities:


Net Income:


Total Cash From Operating Activities:


Sale Purchase Of Stock:


Capital Expenditures:


ATX Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


ATX Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


ATX Share Price History

ATX News

30 May, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
29 Sep, 2019
If you want to know who really controls Amplia Therapeutics Limited (ASX:ATX), then you'll have to look at the makeup...